MIM
GBT

Monashee Investment Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Monashee Investment Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-100,000
Closed -$4.83M – 221
2018
Q1 		$4.83M Buy
+100,000
New +$5.58M 1.33% 26
2017
Q4 		– Hold
0
– – – 15
2017
Q1 		– Hold
0
– – – 31

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Monashee Investment Management's GBT Position: Q2 2018 in Review

Monashee Investment Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2018, closing a stake of 100,000 shares — an estimated $4.83M sold.

Monashee Investment Management first reported a position in GBT in Q1 2018 and held it in 1 quarter. The position peaked at $4.83M in Q1 2018. 196 funds tracked by Wall St. Rank hold GBT as of Q2 2018.

  • Monashee Investment Management reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • Monashee Investment Management sold 100,000 Global Blood Therapeutics, Inc. shares in Q2 2018, an estimated $4.83M.
  • Monashee Investment Management first reported a position in Global Blood Therapeutics, Inc. in Q1 2018 and held it in 1 quarter.
  • Monashee Investment Management's Global Blood Therapeutics, Inc. position peaked at $4.83M in Q1 2018.
  • 196 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2018.

Based on Monashee Investment Management's 13F filing for Q2 2018, filed 10 Aug 2018.